Sumatriptan in pregnancy is considered:

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

Sumatriptan in pregnancy is considered:

Sumatriptan is an abortive migraine medication whose safety in pregnancy is judged by weighing the benefit to the mother against potential fetal risk. Clinical data from pregnancy registries and observational studies have not shown a clear increase in congenital malformations or other major adverse outcomes at typical doses, so the overall clinical stance is that it is acceptable to use when a pregnant person has a disabling migraine and other safer options aren’t sufficient. It’s not absolved of risk, but it is considered safe enough with careful use—lowest effective dose for the shortest duration. It isn’t correct to say it’s universally contraindicated, not studied, or restricted only to the second trimester; those don’t align with the available evidence and guidelines.

Sumatriptan is an abortive migraine medication whose safety in pregnancy is judged by weighing the benefit to the mother against potential fetal risk. Clinical data from pregnancy registries and observational studies have not shown a clear increase in congenital malformations or other major adverse outcomes at typical doses, so the overall clinical stance is that it is acceptable to use when a pregnant person has a disabling migraine and other safer options aren’t sufficient. It’s not absolved of risk, but it is considered safe enough with careful use—lowest effective dose for the shortest duration. It isn’t correct to say it’s universally contraindicated, not studied, or restricted only to the second trimester; those don’t align with the available evidence and guidelines.

More practice questions